본문 바로가기

POPUP LogoPOPUP

팝업건수 : 총 0

닫기 오늘 하루 열지 않기
About Us

Toward Public Health & Safe Society

Organization

R&D Center for Advanced Pharmaceuticals and Evaluation

Goal, Field of Research, Representative Research Result
Goal
  • Research on the development of platform for advanced toxicity and efficacy, and development for advanced disease treatment
  • Develop a disease model with new technology that imagification of spheroid structure in three dimensions, and observe the efficacy of new medicine and toxicity reaction accurately and fast.
Field of Research
  • Develop a stem cell-derived organoids, artificial organs and bio-chip, Bio-signal technology based Mod of Action (MoA) analysis. Computer deep learning model development for sebum-based toxicity and efficacy prediction. Disease treatment development through bio-signal analysis, and drug carriers
  • In Vivo system rarefaction composition and the rarefaction method of vivo system based on this
    • Completed patent registration to America and Japan, and plan to advance to overseas market (Technical transfer to Binaree Inc.)
  • Establish a bio-sensor platform technology for three dimensional cell medicine screening that applied patternized conductive carbon nanotube
Representative Research Result
  • Pharmacological inhibition of mTOR attenuates replicative cell senescence and improves cellular function via regulating the STAT3-PIM1 axis in human cardiac progenitor cells
  • Devices for biological tissue image observation, how to manufacture them, and how to observe biological tissue images using them
  • Transparent giant tissue immune dyeing composition and transparent giant biological immune dyeing method using it
  • myocardial-level biomimic heart chips and their uses

직원리스트 목록 - Department, 이름(이메일), 전화번호, 직급
Department Position Name(Email) Phone
차세대의약평가연구단 단장 김기석( ) 042-610-8089
차세대의약평가연구단 담당 강현수( ) 042-610-8264
차세대의약평가연구단 담당 박순현( ) 042-610-8265
차세대의약평가연구단 담당 박지혜( ) 042-610-8264
차세대의약평가연구단 담당 박채영( ) 042-610-8329
차세대의약평가연구단 담당 안효덕( ) 042-610-8264
차세대의약평가연구단 담당 윤승현( ) 042-610-8329
차세대의약평가연구단 담당 이재면( ) 042-610-8264
차세대의약평가연구단 담당 이재혁( ) 042-610-8338